| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | United States | 5 | |
| #3 | WIPO (World Intellectual Property Organization) | 4 | |
| #4 | Brazil | 2 | |
| #5 | Canada | 2 | |
| #6 | Australia | 1 | |
| #7 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Measurement | |
| #4 | Biotechnology | |
| #5 | Agriculture |
| # | Name | Total Patents |
|---|---|---|
| #1 | Miller Guy M | 11 |
| #2 | Kheifets Viktoria | 5 |
| #3 | Hinman Andrew W | 4 |
| #4 | Wang Bing | 4 |
| #5 | Walkinshaw Gail | 3 |
| #6 | Shrader William D | 3 |
| #7 | Davis Dana | 2 |
| #8 | Guy M Miller | 2 |
| #9 | Gilat Sylvain | 2 |
| #10 | Jankowski Orion D | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2012019032A1 | Treatment of mitochondrial diseases with vitamin k | |
| WO2011113018A1 | Measurement and control of biological time | |
| WO2011041452A2 | Mouse model for identifying compounds for the treatment of oxidative stress | |
| CA2760357A1 | Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases | |
| EP2609921A1 | Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts |